Beta Bionics, Inc. Common Stock (BBNX) Q1 2025 Earnings
BBNX·Reported May 6, 2025·After market close
Beta Bionics, Inc. Common Stock reported Q1 2025 revenue of $17.6M, missed analyst consensus of $19.7M by $2.0M. Diluted EPS came in at $-0.52, missed the $-0.51 consensus by $0.01.
Revenue
$17.6Mmissed by $2.0M
Consensus: $19.7MDiluted EPS
$-0.52missed by $0.01
Consensus: $-0.51
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Beta Bionics, Inc. Common Stock's Q1 2025 earnings report.
Beta Bionics, Inc. Common Stock (BBNX) reported Q1 2025 earnings on May 6, 2025 after market close.
Beta Bionics, Inc. Common Stock reported revenue of $17.6M and diluted EPS of $-0.52 for Q1 2025.
Revenue missed the consensus estimate of $19.7M by $2.0M. EPS missed the consensus estimate of $-0.51 by $0.01.
You can read the 10-Q periodic report (0000950170-25-064504) directly on SEC EDGAR. The filing index links above go to sec.gov.